Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma

Institute of Hematology & Blood Diseases Hospital, China · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
massspectrometrymultiplemyeloma
multiple myeloma, mass spectrometry, serum immunoglobulin, minimal residual disease, mrd, easym, m protein, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 894072
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.